Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding. - Wikidata - awgldk - TriplyDB

Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding.

Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding.

http://www.wikidata.org/entity/Q38066159

about

Statins for the prevention of dementia Statins, cognition, and dementia—systematic review and methodological commentary Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials Modulation of the mevalonate pathway by akt regulates macrophage survival and development of pulmonary fibrosis Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors Dementia and cognitive impairment: epidemiology, diagnosis, and treatment.Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease.Cholesterol in brain disease: sometimes determinant and frequently implicated.Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan.Vascular contributions to cognitive impairment.Bridging the Translation Gap: From Dementia Risk Assessment to Advice on Risk Reduction Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans Simvastatin promotes adult hippocampal neurogenesis by enhancing Wnt/β-catenin signaling.Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Microglial priming in neurodegenerative disease.The Role of PICALM in Alzheimer's Disease.Impact on cognitive function-are all statins the same?Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.Inhibition of Cholesterol Biosynthesis Reduces γ-Secretase Activity and Amyloid-β Generation.Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances.Phytosterols and Dementia.Atorvastatin prevents Aβ oligomer-induced neurotoxicity in cultured rat hippocampal neurons by inhibiting Tau cleavage PCSK9 inhibitors and neurocognitive adverse events: exploring the FDA directive and a proposal for N-of-1 trials.Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms.Role of LDL cholesterol and endolysosomes in amyloidogenesis and Alzheimer's disease.Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD.Statins and Cognition in Parkinson's Disease.Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin bac Effects of Plasma Lipids and Statins on Cognitive Function.The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms.Long-term statin use and dementia risk in Taiwan.Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis.Microglial priming in Alzheimer's disease.

P2860

Q24186591-C175A7DC-51CF-4E7D-AC7F-E1E6457ED3C2 Q26852778-C3D56063-DF41-439E-8D14-9914ACABFFEB Q28085282-A14AA0E7-BD89-4F82-90CE-2D7FD5260C49 Q28385018-825B4207-19ED-4857-B588-04E30AFBEE36 Q30814231-9BD72A01-84BE-4395-B2A8-AD1D9E3C0A33 Q33924014-33302DF9-08A0-4D81-900A-E795B816A114 Q34536301-CC259AC0-23E4-46DC-9807-1DAC9A6CC76F Q34621446-FFB15131-6B41-4C16-9529-C8AB99DCF9F3 Q35092836-2AA8B9D2-C55F-4BD1-953B-2435F00E75A0 Q35747960-4B47BE20-1643-44FF-9F88-ECFB8F88D88A Q36057021-D87E851A-6F3B-4D9B-B332-CE8AB631F73D Q36351416-74E5992D-F331-497F-8570-E307A8F5EB37 Q37564301-3F95A716-FA22-443A-8BA4-B31D17F38EFC Q38119019-81BDC9A4-2E3E-4ACD-B882-92B03FFAB29C Q38125769-27E6C7A7-AC5B-48D0-A00E-6B0CDE15C8D0 Q38196699-633C0D6B-0A53-4E83-8F28-F689A778D061 Q38245888-0728F20D-5EAB-48BA-9DCE-8773AC97291A Q38268341-9224F653-1809-4940-BF35-865BE4EE4848 Q38414035-2FA56232-96DD-41D6-BEC9-8C78171EBE74 Q38790457-1271DCB0-664D-4867-9B19-8EA526EB6FB5 Q38936146-260B0101-442E-4282-9FD2-68E4AB0B3454 Q38963194-A7906E0E-22C4-4631-9EA8-4A62FF9A4DB5 Q40378989-55CCBAE8-14EA-4309-8B72-7329136813EF Q40923280-CB3DE10B-E8C3-41D4-BA7E-64AFC013D1FD Q41848796-72211069-0637-4883-8325-B1839BA52741 Q42736295-AD34F199-B220-4E2C-B1E1-3EEF033E9FE3 Q43115550-E763FA5B-5755-466A-9F9E-6907F8BF6EF5 Q46305058-FAC80C44-7C0F-45B2-9ADF-A30E374365CA Q46535385-6FE41957-E7E5-454F-8A27-735A82968F17 Q46904301-89BED82B-A332-4683-B7E8-829F4BF2BF56 Q49941044-F8F255E1-21C4-484C-925D-08D5BCE712FC Q50532477-72A99C9B-0B24-4DE0-A13D-0BF2B32BAF33 Q50657607-5A944EDB-317F-4D8C-B7AC-98DCC3D67BB7 Q52317633-528AD0EF-2315-4B73-A09F-23BCCD308CED Q55358469-28DCFCE4-01DF-48D7-880D-0C59B793034C

P2860

Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding.

http://www.wikidata.org/entity/Q38066159

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Statins in the prevention of d ...... an assessment of confounding.

@en

type

label

Statins in the prevention of d ...... an assessment of confounding.

@en

prefLabel

Statins in the prevention of d ...... an assessment of confounding.

@en

P1433

Q38066159-49E341F4-C72A-44C1-9C61-12BD13CD8D5E

P1476

Q38066159-EEAAC429-00E0-420F-B0F3-E23C1A24706A

P2093

Q38066159-54A5A43B-23E9-4B9D-BFFA-2F48A69E8BC5

Q38066159-773B1061-4336-4C99-8127-5265DF48DBF8

Q38066159-7E74DDBB-8959-4CB7-A08E-710A6EE572CA

Q38066159-A6D07ECC-1B79-4BCB-973A-1679A7DD04F5

P2860

Q38066159-0AB9881B-3176-442C-8576-D0FFA403FFA3

Q38066159-2570B10E-F8D7-4525-9B5D-CEB952460E37

Q38066159-28DAE7F9-FE5B-416E-BE91-B8A853C68B94

Q38066159-2DB7AAEA-A2B7-4067-BBA8-158DCF699CB0

Q38066159-37FBE5BA-A670-4681-A8E4-051BB0FD4514

Q38066159-3AC6FB3C-0398-4663-A667-73A3EF2A9824

Q38066159-4038FEF8-C183-4B15-82A3-4F4B8D265550

Q38066159-4315137A-0CE9-4387-A38A-40B1100EAB59

Q38066159-44CEC260-9D86-47FB-A55C-CE35EDB326BC

Q38066159-44F5285B-1B45-4DCA-9FE3-5F64C728E446

P304

Q38066159-12CBDA39-B0FD-48E1-831E-C306329FF7A5

P31

Q38066159-0027602c-fec1-4e42-99da-1232562f0d28

Q38066159-97EAB8C9-4BF3-4B9D-8BF9-9F211C9A9CA7

P356

Q38066159-5B808941-5A34-49D1-BF3A-B3F6737AC7F7

P433

Q38066159-6D79D013-6FCF-45FB-B8ED-2B502535F690

P478

Q38066159-D8D1FD33-BDBF-400D-91A4-585394FF4945

P50

Q38066159-D03D71FC-F734-4D9C-8830-CF5E2E032356

P577

Q38066159-EAF1BD7E-EB4D-4E2E-972B-D9D450AC0F53

P698

Q38066159-569867B5-2267-48B5-8BCC-F3B46B44A58D

P921

Q38066159-E7EA7998-064B-42D1-A9DD-43B924267D7C

P356

P1433

Pharmacoepidemiology and Drug Safety

P1476

Statins in the prevention of d ...... an assessment of confounding.

@en

P2093

Denise Boudreau

http://www.w3.org/2001/XMLSchema#string

Emily Beth Devine

http://www.w3.org/2001/XMLSchema#string

Vincent W Lin

http://www.w3.org/2001/XMLSchema#string

William B Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

Bias in meta-analysis detected by a simple, graphical test

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Meta-analysis in clinical trials

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies.

Association of statin use with cognitive decline in elderly African Americans.

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

P304

345-358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.3381

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Emily Beth Devine

P577

2012-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23225700

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease